Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Staniszewska, Anna"'
Autor:
Sacco A; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Federico C; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Todoerti K; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Ziccheddu B; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., Palermo V; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Giacomini A; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Ravelli C; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Maccarinelli F; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Bianchi G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Belotti A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Ribolla R; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Favasuli V; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Revenko AS; Ionis Pharmaceuticals, Carlsbad, CA., Macleod AR; Ionis Pharmaceuticals, Carlsbad, CA., Willis B; Oncology R &D, AstraZeneca, Waltham, MA., Cai H; Oncology R &D, AstraZeneca, Waltham, MA., Hauser J; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Rooney C; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Willis SE; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Martin PL; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD., Staniszewska A; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Ambrose H; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Hanson L; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Cattaneo C; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Tucci A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Rossi G; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Ronca R; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Neri A; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Mitola S; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Bolli N; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Presta M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Moschetta M; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Ross S; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Roccaro AM; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy.
Publikováno v:
Blood [Blood] 2021 Nov 04; Vol. 138 (18), pp. 1705-1720.